Australia's LBT Innovations soars on sale of instruments

Clever Culture Systems

07/08/2024 01:37

** Shares of LBT Innovations  LBT.AX  rise as much as 73.3%
to A$0.026, their highest since April 5
    ** Stock posts its biggest intraday pct gain since March 13
    ** Medical technology firm says it has signed agreement to
sell five APAS Independence instruments to AstraZeneca  AZN.L 
with total contract value between $2.2 mln and $2.7 mln
    ** APAS Independence is an in vitro diagnostic instrument
for the automated imaging, analysis and interpretation of agar
culture plates
    ** About 9.9 mln LBT shares change hands, compared with the
30-day average volume of 1.5 mln
    ** Stock had risen 36.4% this year, as of last close

 (Reporting by Sneha Kumar in Bengaluru)
 ((Sneha.Kumar@thomsonreuters.com;))